XML 38 R19.htm IDEA: XBRL DOCUMENT v3.3.0.814
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2015
Earnings Per Share.  
Schedule of components of the calculations of basic and diluted earnings per share:

 

The following table provides the components of the calculations of basic and diluted earnings per share (in thousands, except share amounts):

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30, 2015

 

September 30, 2014

 

September 30, 2015

 

September 30, 2014

 

Numerator:

 

 

 

 

 

 

 

 

 

Net loss attributable to common shareholders

 

$

(10,238

)

$

(9,377

)

$

(30,568

)

$

(81,461

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding

 

177,369,017

 

169,557,223

 

174,724,746

 

154,539,225

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Schedule of potential dilutive common shares

 

                                                                                                                                                                                                                

 

 

At September 30,

 

 

 

2015

 

2014

 

Stock options outstanding

 

11,789,611 

 

7,267,404 

 

Restricted stock outstanding

 

395,558 

 

433,336 

 

Common stock warrants (1)

 

4,192,567 

 

4,219,442 

 

Preferred stock (2)

 

5,554,594 

 

5,554,594 

 

 

 

 

 

 

 

Number of dilutive potential common shares

 

21,932,330 

 

17,474,776 

 

 

 

 

 

 

 

 

 

(1)

During the three months ended September 30, 2015 and 2014, the Company granted 3,270,000 and 2,454,000 stock options, respectively.  During the nine months ended September 30, 2015 and 2014, the Company granted 3,920,000 and 3,140,000 stock options, respectively.

(2)

In May 2011, the Company issued 7,128,563 warrants as part of an underwritten public offering.  As a result of additional public offerings, and pursuant to the effect of the anti-dilution provisions of these warrants, the number of warrants increased to 22,995,365.  Of these warrants, 192,467 and 219,349 were unexercised as of September 30, 2015 and 2014, respectively.  In February 2013, the Company issued 23,637,500 warrants as part of an underwritten public offering.  Of these warrants, 100 were unexercised as of September 30, 2015 and 2014.  In January 2014, the Company issued 4,000,000 warrants as part of an underwritten public offering.  Of these warrants, all are unexercised as of September 30, 2015 and 2014.  As of September 30, 2015, the remaining warrants have a weighted average exercise price of $3.86.

(3)

The preferred stock amount represents the dilutive potential common shares of the Series C redeemable convertible preferred stock issued on May 16, 2013 based on the conversion price of the preferred stock as of September 30, 2015.  Of the 10,431 preferred shares issued in May 2013, 5,200 had been converted to common stock as of September 30, 2015.